1. McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China 2. Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
Cystic fibrosis (CF) is a rare autosomal recessive disease with only one pathogenic gene cystic fibrosis transmembrane conductance regulator (CFTR). To identify the potential pathogenic mutations in a Chinese patient with CF, we conducted Sanger sequencing on the genomic DNA of the patient and his parents and detected all 27 coding exons of CFTR and their flanking intronic regions. The patient is a compound heterozygote of c.2909G>A, p.Gly970Asp in exon 18 and c.1210-3C>G in cis with a poly-T of 5T (T5) sequence, 3 bp upstream in intron 9. The splicing effect of c.1210-3C>G was verified via minigene assay in vitro, indicating that wild-type plasmid containing c.1210-3C together with T7 sequence produced a normal transcript and partial exon 10-skipping-transcript, whereas mutant plasmid containing c.1210-3G in cis with T5 sequence caused almost all mRNA to skip exon 10. Overall, c.1210-3C>G, the newly identified pathogenic mutation in our patient, in combination with T5 sequence in cis, affects the CFTR gene splicing and produces nearly no normal transcript in vitro. Moreover, this patient carries a p.Gly970Asp mutation, thus confirming the high-frequency of this mutation in Chinese patients with CF.
JR Riordan, JM Rommens, B Kerem, N Alon, R Rozmahel, Z Grzelczak, J Zielenski, S Lok, N Plavsic, JL Chou, et al..Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245(4922): 1066–1073 https://doi.org/10.1126/science.2475911
pmid: 2475911
B Marshall, A Elbert, K Petren, M Grimes, A Fink, V Myers, A Sewall. Cystic Fibrosis Foundation Patient Registry 2013 Annual Data Report to the Center Directors. Cystic Fibrosis Foundation 2014
4
BJ Rosenstein, GR Cutting. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998; 132(4): 589–595 https://doi.org/10.1016/S0022-3476(98)70344-0
pmid: 9580754
5
A Sahami, R Alibakhshi, K Ghadiri, H Sadeghi. Mutation analysis of exons 10 and 17a of CFTR gene in patients with cystic fibrosis in Kermanshah Province, Western Iran. J Reprod Infertil 2014; 15(1): 49–56
pmid: 24696795
6
SM Moskowitz, JF Chmiel, DL Sternen, E Cheng, RL Gibson, SG Marshall, GR Cutting. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med 2008; 10(12): 851–868 https://doi.org/10.1097/GIM.0b013e31818e55a2
pmid: 19092437
7
X Tian, Y Liu, J Yang, H Wang, T Liu, W Xu, X Li, Y Zhu, KF Xu, X Zhang. p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis. Hum Genome Var 2016; 3(1): 15063 https://doi.org/10.1038/hgv.2015.63
pmid: 27081564
8
Y Liu, L Wang, X Tian, KF Xu, W Xu, X Li, C Yue, P Zhang, Y Xiao, X Zhang. Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients. Respirology 2015; 20(2): 312–318 https://doi.org/10.1111/resp.12452
pmid: 25580864
9
X Guo, K Liu, Y Liu, Y Situ, X Tian, KF Xu, X Zhang. Clinical and genetic characteristics of cystic fibrosis in Chinese patients: a systemic review of reported cases. Orphanet J Rare Dis 2018; 13(1): 224 https://doi.org/10.1186/s13023-018-0968-2
pmid: 30558651
10
CS Chu, BC Trapnell, S Curristin, GR Cutting, RG Crystal. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993; 3(2): 151–156 https://doi.org/10.1038/ng0293-151
pmid: 7684646
11
SJ Delaney, DP Rich, SA Thomson, MR Hargrave, PK Lovelock, MJ Welsh, BJ Wainwright. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat Genet 1993; 4(4): 426–430 https://doi.org/10.1038/ng0893-426
pmid: 7691356
12
P Gaildrat, A Killian, A Martins, I Tournier, T Frébourg, M Tosi. Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol Biol 2010; 653: 249–257 https://doi.org/10.1007/978-1-60761-759-4_15
pmid: 20721748
13
DB Salinas, C Azen, S Young, TG Keens, M Kharrazi, RB Parad. Phenotypes of California CF newborn screen-positive children with CFTR 5T allele by TG repeat length. Genet Test Mol Biomarkers 2016; 20(9): 496–503 https://doi.org/10.1089/gtmb.2016.0102
pmid: 27447098
14
Q Huang, W Ding, MX Wei. Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population. World J Gastroenterol 2008; 14(12): 1925–1930 https://doi.org/10.3748/wjg.14.1925
pmid: 18350634
15
F Amato, P Scudieri, I Musante, V Tomati, E Caci, M Comegna, S Maietta, F Manzoni, AM Di Lullo, E De Wachter, E Vanderhelst, V Terlizzi, C Braggion, G Castaldo, LJV Galietta. Two CFTR mutations within codon 970 differently impact on the chloride channel functionality. Hum Mutat 2019; 40(6): 742–748 https://doi.org/10.1002/humu.23741
pmid: 30851139
16
S Kiesewetter, M Macek Jr, C Davis, SM Curristin, CS Chu, C Graham, AE Shrimpton, SM Cashman, LC Tsui, J Mickle, J Amos, WE Highsmith, A Shuber, DR Witt, RG Crystal, GR Cutting. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5(3): 274–278 https://doi.org/10.1038/ng1193-274
pmid: 7506096
17
RA de Nooijer, JM Nobel, HG Arets, AG Bot, FT van Berkhout, YB de Rijke, HR de Jonge, I Bronsveld. Assessment of CFTR function in homozygous R117H-7T subjects. J Cyst Fibros 2011; 10(5): 326–332 https://doi.org/10.1016/j.jcf.2011.03.009
pmid: 21507732
18
S Kimura, Y Okabayashi, K Inushima, Y Yutsudo, M Kasuga. Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig Dis Sci 2000; 45(10): 2007–2012 https://doi.org/10.1023/A:1005500210281
pmid: 11117575
19
RJ Gregory, DP Rich, SH Cheng, DW Souza, S Paul, P Manavalan, MP Anderson, MJ Welsh, AE Smith. Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 1991; 11(8): 3886–3893 https://doi.org/10.1128/MCB.11.8.3886
pmid: 1712898